Suppr超能文献

比较手术切除脑转移瘤单次立体定向放射外科治疗的术前与术后剂量学计划。

Comparison of preoperative versus postoperative treatment dosimetry plans of single-fraction stereotactic radiosurgery for surgically resected brain metastases.

机构信息

Departments of1Neurosurgery.

2Radiation Oncology, and.

出版信息

Neurosurg Focus. 2023 Aug;55(2):E9. doi: 10.3171/2023.5.FOCUS23209.

Abstract

OBJECTIVE

Stereotactic radiosurgery (SRS) for operative brain metastasis (BrM) is usually administered 1 to 6 weeks after resection. Preoperative versus postoperative timing of SRS delivery related to surgery remains a critical question, as a pattern of failure is the development of leptomeningeal disease (LMD) in as many as 35% of patients who undergo postoperative SRS or the occurrence of radiation necrosis. As they await level I clinical data from ongoing trials, the authors aimed to bridge the gap by comparing postoperative with simulated preoperative single-fraction SRS dosimetry plans for patients with surgically resected BrM.

METHODS

The authors queried their institutional database to retrospectively identify patients who underwent postoperative Gamma Knife SRS (GKSRS) after resection of BrM between January 2014 and January 2021. Exclusion criteria were prior radiation delivered to the lesion, age < 18 years, and prior diagnosis of LMD. Once identified, a simulated preoperative SRS plan was designed to treat the unresected BrM and compared with the standard postoperative treatment delivered to the resection cavity per Radiation Therapy Oncology Group (RTOG) 90-05 guidelines. Numerous comparisons between preoperative and postoperative GKSRS treatment parameters were then made using paired statistical analyses.

RESULTS

The authors' cohort included 45 patients with a median age of 59 years who were treated with GKSRS after resection of a BrM. Primary cancer origins included colorectal cancer (27%), non-small cell lung cancer (22%), breast cancer (11%), melanoma (11%), and others (29%). The mean tumor and cavity volumes were 15.06 cm3 and 12.61 cm3, respectively. In a paired comparison, there was no significant difference in the planned treatment volumes between the two groups. When the authors compared the volume of surrounding brain that received 12 Gy or more (V12Gy), an important predictor of radiation necrosis, 64% of patient plans in the postoperative SRS group (29/45, p = 0.008) recorded greater V12 volumes. Preoperative plans were more conformal (p < 0.001) and exhibited sharper dose drop-off at the lesion margins (p = 0.0018) when compared with postoperative plans.

CONCLUSIONS

Comparison of simulated preoperative and delivered postoperative SRS plans administered to the BrM or resection cavity suggested that preoperative SRS allows for more highly conformal lesional coverage and sharper dose drop-off compared with postoperative plans. Furthermore, V12Gy was lower in the presurgical GKSRS plans, which may account for the decreased incidence of radiation necrosis seen in prior retrospective studies.

摘要

目的

手术脑转移瘤(BrM)的立体定向放射外科(SRS)治疗通常在切除后 1 至 6 周内进行。SRS 给药的术前与术后时间与手术相关,仍然是一个关键问题,因为多达 35%的接受术后 SRS 或发生放射性坏死的患者会出现进展性软脑膜疾病(LMD)。在等待正在进行的试验的一级临床数据的同时,作者旨在通过比较接受手术切除 BrM 后接受术后与模拟术前单次 SRS 剂量计划的患者来填补空白。

方法

作者通过查询他们的机构数据库,回顾性地确定了 2014 年 1 月至 2021 年 1 月期间接受术后伽玛刀 SRS(GKSRS)治疗的 BrM 手术后患者。排除标准为对病变部位进行过放射治疗、年龄<18 岁以及先前诊断为 LMD。一旦确定,设计了一个模拟的术前 SRS 计划来治疗未切除的 BrM,并根据放射治疗肿瘤学组(RTOG)90-05 指南与标准的术后治疗切除腔进行比较。然后使用配对统计分析比较术前和术后 GKSRS 治疗参数之间的许多比较。

结果

作者的队列包括 45 名中位年龄为 59 岁的患者,他们在切除 BrM 后接受了 GKSRS 治疗。原发癌起源包括结直肠癌(27%)、非小细胞肺癌(22%)、乳腺癌(11%)、黑色素瘤(11%)和其他(29%)。肿瘤和腔的平均体积分别为 15.06cm3 和 12.61cm3。在配对比较中,两组之间的计划治疗体积没有显著差异。当作者比较 12Gy 或更高(V12Gy)的周围脑体积时,术后 SRS 组 64%的患者计划(29/45,p=0.008)记录了更大的 V12 体积。与术后计划相比,术前计划更符合适形(p<0.001),在病变边缘的剂量下降更陡峭(p=0.0018)。

结论

对 BrM 或切除腔进行模拟术前和术后 SRS 计划的比较表明,与术后计划相比,术前 SRS 可实现更高度适形的病变覆盖和更陡峭的剂量下降。此外,术前 GKSRS 计划的 V12Gy 更低,这可能是先前回顾性研究中观察到放射性坏死发生率降低的原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验